Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates

References

• Basser RL, O’Flaherty E, Green M, Edmonds M, Nichol J, Menchaca DM, Cohen B, Begley CG. 2002. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood. 99:2599–2602.
   PubMed Web of Science ®Google Scholar
• Broudy VC, Lin NL. 2004. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine. 25:52–60.
   PubMed Web of Science ®Google Scholar
• Farese AM, Cohen MV, Katz BP, Smith CP, Gibbs A, Cohen DM, MacVittie TJ. 2013. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 179:89–100.
   PubMed Web of Science ®Google Scholar
• Farese AM, Cohen MV, Katz BP, Smith CP, Jackson W, 3rd, Cohen DM, MacVittie TJ. 2012. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. Health Phys. 103:367–382.
   PubMed Web of Science ®Google Scholar
• Farese AM, Hunt P, Grab LB, MacVittie TJ. 1996. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest. 97:2145–2151.
   PubMed Web of Science ®Google Scholar
• Gourmelon P, Benderitter M, Bertho JM, Huet C, Gorin NC, De Revel P. 2010. European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal. Health Phys. 98:825–832.
   PubMed Web of Science ®Google Scholar
• Grossmann A, Lenox J, Deisher TA, Ren HP, Humes JM, Kaushansky K, Sprugel KH. 1996. Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice. Blood. 88:3363–3370.
   PubMed Web of Science ®Google Scholar
• Hall E. 2000. Acute effects of total-body irradiation. Radiobiology for the radiologist. Philadelphia (PA): Lippincott Williams & Wilkins; p. 124–135.
   Google Scholar
• Hankey KG, Farese AM, Blaauw EC, Gibbs AM, Smith CP, Katz BP, Tong Y, Prado KL, MacVittie TJ. 2015. Pegfilgrastim improves survival of lethally irradiated nonhuman primates. Radiat Res. 183:643–655.
   PubMed Web of Science ®Google Scholar
• Heil G, Hoelzer D, Sanz MA, Lechner K, Liu Yin JA, Papa G, Noens L, Szer J, Ganser A, O’Brien C, The International Acute Myeloid Leukemia Study Group, et al. 1997. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood. 90:4710–4718.
   PubMed Web of Science ®Google Scholar
• Hirouchi T, Ito K, Nakano M, Monzen S, Yoshino H, Chiba M, Hazawa M, Nakano A, Ishikawa J, Yamaguchi M, et al. 2015. Mitigative effects of a combination of multiple pharmaceutical drugs on the survival of mice exposed to lethal ionizing radiation. Curr Pharm Biotechnol. 17:190–199.
   PubMed Web of Science ®Google Scholar
• Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S. 2014. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer. 83:97–101.
   PubMed Web of Science ®Google Scholar
• Kohler A, De Filippo K, Hasenberg M, van den Brandt C, Nye E, Hosking MP, Lane TE, Mann L, Ransohoff RM, Hauser AE, et al. 2011. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood. 117:4349–4357.
   PubMed Web of Science ®Google Scholar
• Krigsfeld GS, Kennedy AR. 2013. Is disseminated intravascular coagulation the major cause of mortality from radiation at relatively low whole body doses? Radiat Res. 180:231–234.
   PubMed Web of Science ®Google Scholar
• Krigsfeld GS, Savage AR, Billings PC, Lin L, Kennedy AR. 2014. Evidence for radiation-induced disseminated intravascular coagulation as a major cause of radiation-induced death in ferrets. Int J Radiat Oncol Biol Phys. 88:940–946.
   PubMed Web of Science ®Google Scholar
• Krigsfeld GS, Shah JB, Sanzari JK, Lin L, Kennedy AR. 2014. Evidence of disseminated intravascular coagulation in a porcine model following radiation exposure. Life Sci Space Res (Amst). 3:1–9.
   PubMedGoogle Scholar
• Ku H, Yonemura Y, Kaushansky K, Ogawa M. 1996. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood. 87:4544–4551.
   PubMed Web of Science ®Google Scholar
• Kumagai S, Tokuno J, Ueda Y, Marumo S, Shoji T, Nishimura T, Fukui M, Huang CL. 2015. Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer. Mol Clin Oncol. 3:197–201.
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, et al. 2008. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 371:395–403.
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP. 2010. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med. 363:1889–1899.
   PubMed Web of Science ®Google Scholar
• Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, Kuter DJ. 2001. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 98:3241–3248.
   PubMed Web of Science ®Google Scholar
• Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G. 1997. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol. 25:1084–1093.
   PubMed Web of Science ®Google Scholar
• Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G. 1997. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys. Blood. 90:2565–2573.
   PubMed Web of Science ®Google Scholar
• NEULASTA®. 2018. (Pegfilgrastrim) [product monograph]. Thousand Oaks (CA): Amgen Inc.
   Google Scholar
• NEUPOGEN®. 2018. (Filgrastim) [product monograph]. Thousand Oaks (CA): Amgen Inc.
   Google Scholar
• Nichol JL. 1998. The Mpl ligand and platelet homeostasis. Acta Paediatr Suppl. 424:7–15.
   PubMedGoogle Scholar
• NPLATE®. 2018. (Romiplostim) [product monograph]. Thousand Oaks (CA): Amgen Inc.
   Google Scholar
• Panopoulos AD, Watowich SS. 2008. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis. Cytokine. 42:277–288.
   PubMed Web of Science ®Google Scholar
• Sheridan WP, Choi E, Toombs CF, Nichol J, Fanucchi M, Basser RI. 1997. Biology of thrombopoiesis and the role of Mpl ligand in the production and function of platelets. Platelets. 8:319–332.
   PubMed Web of Science ®Google Scholar
• Singh VK, Olabisi AO. 2017. Nonhuman primates as models for the discovery and development of radiation countermeasures. Expert Opin Drug Discov. 12:695–709.
   PubMed Web of Science ®Google Scholar
• Sitnicka E, Lin N, Priestley GV, Fox N, Broudy VC, Wolf NS, Kaushansky K. 1996. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood. 87:4998–5005.
   PubMed Web of Science ®Google Scholar
• Stickney DR, Dowding C, Authier S, Garsd A, Onizuka-Handa N, Reading C, Frincke JM. 2007. 5-androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression. Int Immunopharmacol. 7:500–505.
   PubMed Web of Science ®Google Scholar
• Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. 1984. Platelet size and age determine platelet function independently. Blood. 63:1372–1375.
   PubMed Web of Science ®Google Scholar
• Vogel CL, Wojtukiewicz MZ, Carroll RR, Tjulandin SA, Barajas-Figueroa LJ, Wiens BL, Neumann TA, Schwartzberg LS. 2005. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol. 23:1178–1184.
   PubMed Web of Science ®Google Scholar
• Wang B, Nichol JL, Sullivan JT. 2004. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther. 76:628–638.
   PubMed Web of Science ®Google Scholar
• Wendling F, Cohen-Solal K, Debili N, Villeval JL, Titeux M, Vainchenker W. 1996. [Mpl ligand (thrombopoietin) and platelet regulation]. Ann Pharm Fr. 54:177–182.
   PubMedGoogle Scholar
• Yamaguchi M, Hirouchi T, Yokoyama K, Nishiyama A, Murakami S, Kashiwakura I. 2018. The thrombopoietin mimetic romiplostim leads to the complete rescue of mice exposed to lethal ionizing radiation. Sci Rep. 8:10659.
   PubMed Web of Science ®Google Scholar